NCT00908544 - New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2009

Primary Completion Date

April 3, 2018

Study Completion Date

May 31, 2018

Conditions

HIV Infections

Interventions

OTHER

PHI-patients

Treatment initiation with multi drug class (MDC) HAART. 2 NRTI + 1 PI/r + Maraviroc + Raltegravir

OTHER

CHI-patients

Treatment intensification of PI-based HAART with Maraviroc and Raltegravir. 2 NRTI + 1 PI/r + Maraviroc + Raltegravir

Trial Locations (8)

ICH Study Center, Hamburg

Private Practice for Internal Medicine, Hematology and Oncology, Mannheim

Private Practice Drs Ulmer/Frietsch/Mueller, Stuttgart

Onkology Karlsruhe, Karlsruhe

Private Practice Drs Pauli/Becker, Munich

MVZ Karlsplatz, Munich

University Munich University Hospital, Dept. of Infectious Diseases, Munich

Practice Dr. med. Lothar Schneider, Fürth